Form D Explorer
NextPoint Therapeutics, Inc. · CIK 1959209

Citable research briefCompare issuerPrivate research collection

NextPoint Therapeutics, Inc.

CIK 1959209 · Corporation · Inc. DELAWARE · CAMBRIDGE, MA · Biotechnology
https://nextpointtx.com (possible website — auto-inferred, not verified)
Sign up to follow
Filings
1
Original notices
1
Amendments
0
Activity
Jul 30, 2026
through Jul 30, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Jul 30, 2026

Reported offering amount
$48,729,165
Reported amount sold
$33,728,772

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (1)